SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RXGOLF who wrote (15424)2/20/1998 12:06:00 AM
From: Machaon  Read Replies (1) of 32384
 
<< By the way, some here have even done well with Ligand even though you note the price is about the same. >>

I've been in and out of lGND. At present I am long only and not trading. It might take a while, but I want to be holding when and if LGND pops.

Since there has been some discussion about the news releases, let's take a look and see what one of them means. Comments are welcome!

<< SAN DIEGO, Feb. 19 /PRNewswire/ -- Ligand Pharmaceuticals Inc. (Nasdaq: LGND) has announced the appointment of Philip A. Duffy to the newly created position of Vice President, Technical Operations.

Mr. Duffy will oversee Ligand's chemical, formulations and analytical
development activities for commercial products, as well as manufacturing, purchasing, and materials management functions.
>>

It's a newly created position. The positive side is that Ligand might be getting ready for another corporate function. The negative spin would be that Ligand needed a slot to reward one of their members of management. Any comments?

Next: "Mr. Duffy will oversee Ligand's chemical, formulations and analytical development activities for commercial products"

What commercial products? Perhaps this is a misstatement. Might we get a corrected release tomorrow saying "products under development" rather than "commercial products"? I guess that it is possible. If Ligand doesn't correct the news release, then what do they mean by commercial products? Could they be interested in selling peanut butter after reading this thread?

<< as well as manufacturing, purchasing, and materials management functions >>

Could they be referring to the drugs under development? Why would they need someone in charge of manufacturing, etc., at this stage in testing? I guess it is possible. Could they be referring to the "ramping up" towards commercialization of products after FDA approval? Hmmmm!? They did say commercial products". To me this is a significant news release. It should have a positive effect on LGND tomorrow. Perhaps we'll see a move up of around 3/8? Anyone got an opinion?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext